Agila Specialty Formulation FAcility

Mylan NV (NASDAQ: MYL) commented publicly for the first time to a FDA warning letter which it received on August 6, relating to its Agila Specialty Formulation Facility (SFF), Sterile Product Division (SPD), and Onco Therapies Limited (OTL) sites in India. In a press release, Mylan's CEO...